(Q37620267)

21 August 2017

1 reference

title

Current progress in the treatment of the child with cancer (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

29 May 2022

author name string

A. M. Mauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198520

29 May 2022

J. V. Simone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198520

29 May 2022

C. B. Pratt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A198520

29 May 2022

language of work or name

English

0 references

publication date

1 October 1977

1 reference

full work available at URL

21 August 2017

https://api.elsevier.com/content/article/PII:S0022347677804976?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

https://api.elsevier.com/content/article/PII:S0022347677804976?httpAccept=text/plain

29 May 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

The Journal of Pediatrics

29 May 2022

published in

1 reference

21 August 2017

volume

91

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

523-539

1 reference

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The DNA Provirus Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The Epstein-Barr Virus and Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Growth and differentiation in culture of leukemic leukocytes from a patient with acute myelogenous leukemia and re-identification of type-C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

A survey of childhood malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Leukemia from low-level radiation: identification of susceptible children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Relationship Between Human Teratogens and Carcinogens2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Risk of second tumors in survivors of childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Decreased risk of radiation-associated second malignant neoplasms in actinomycin-d-treated patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Part III: 7th Walter Hubert lecture. Pott and the prospects for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Sporadic bilateral retinoblastoma and 13q- chromosomal deletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Cell kinetics and practical consequences for therapy of acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Total-body sequential segmental irradiation and combination chemotherapy for children with disseminated neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Cessation of Therapy during Complete Remission of Childhood Acute Lymphocytic Leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The treatment of Wilms' tumor. Results of the national Wilms' tumor study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Initial features and prognosis in 363 children with acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Morphological Criteria for Prognostication of Acute Lymphoblastic Leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Lack of correlation of lymphoblast cell size with presence of T-cell markers or with outcome in childhood acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Factors that influence haematological remission duration in acute lymphocytic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Drug dosage and remission duration in childhood lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Prevention of central nervous system leukemia by irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Active immunotherapy for acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Acute lymphocytic leukemia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Acute nonlymphocytic leukemia in 171 children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Classification of chronic myelocytic leukemia in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Considerations in the radiation therapy of Wilms' tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Chemotherapy in the treatment of leukemia and Wilms' tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Childhood malignant tumors. Concurrent chemotherapy with dactinomycin and vincristine sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Vincristine sulfate and radiation therapy in metastatic Wilms' tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Single versus multiple dose dactinomycin therapy of Wilms's tumor. A controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Clinical and pathologic staging as a guide in the management of Wilms' tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Preoperative therapy for unresectable malignant tumors in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Non-Oncogenic Sequelae of Cancer Chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Oncogenesis and Other Late Effects of Cancer Treatment in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Neuroblastoma, its natural history and prognosis: a study of 487 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Factors influencing survival of children with nonmetastatic neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

CYCLOPHOSPHAMIDE THERAPY IN CHILDHOOD NEUROBLASTOMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Vincristine Sulfate in the Treatment of Neuroblastoma in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Survival of children with neuroblastoma treated with combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Cell kinetics and chemotherapy in neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Response of childhood rhabdomyosarcoma to combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The role of combined chemotherapy in the treatment of rhabdomyosarcoma in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Combined therapy in childhood rhabdomyosarcoma: an analysis of 42 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Rhabdomyosarcoma of head and neck in children. Combination treatment by surgery, irradiation, and chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Multidisciplinary treatment of embryonal rhabdomyosarcoma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Rhabdomyosarcoma in children. Improved outlook with a multidisciplinary approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Doxorubicin in disseminated osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Amputation and Adriamycin in Primary Osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Transmedullary amputation and resection of metastases in combined therapy of osteosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Chemotherapy,en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Ewing's sarcoma.Case against surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The curability of Ewing's endothelioma of bone in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Treatment of clinically localized Ewing's sarcoma with radiotherapy and combination chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Past failures and future possibilities in Ewing's sarcoma:Experimental and preliminary clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Combined modality therapy of Ewing's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Localized Ewing's sarcoma--treatment and results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Proceedings: Disease-free survival in children with Ewing's sarcoma treated with radiation therapy and adjuvant four-drug sequential chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The value of laparotomy and splenectomy in the staging of Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Preliminary Experience with Total Nodal Irradiation in Hodgkin's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Concurrent chemotherapy and radiation therapy in the treatment of childhood and adolescent Hodgkin's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Comparison of the clinical course of Hodgkin's disease in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Non-Hodgkin's lymphomas. VI. Results of treatment in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Therapy of localized and regional lymphosarcoma of childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

A study of childhood non-hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

7 January 2021

Treatment of lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

The role of radiation therapy in localized resectable intestinal non-Hodgkin's lymphoma in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Non-hodgkin's lymphoma in children: Correlation of CNS disease with initial presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Non-Hodgkin lymphoma of the head and neck in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2877%2980497-6

Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) Activities in normal, neoplastic, differentiating, and regenerating liver

7 January 2021

20

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

Doxorubicin in treatment of malignant solid tumors in children

29 May 2022

54

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

Cyclophosphamide (Cytoxan) therapy of childhood neuroblastoma. Preliminary report

29 May 2022

63

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

Combination intermittent chemotherapy for patients with disseminated neuroblastoma

29 May 2022

Evidence for an orderly progression in the spread of Hodgkin's disease

68

0 references

102

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(77)80497-6

29 May 2022

Identifiers

1 reference

21 August 2017

1 reference